Medications

Weight Loss Drugs Diabetes Treatment GLP-1 Drugs Over-the-Counter Drugs GLP-1 Receptor Agonists Prescription Drugs Weight Loss Diabetes Weight Management Weight Loss Treatments

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

The move targets localized production of the oral GLP-1 to strengthen supply ahead of potential approvals.

Large VA Study Links GLP-1 Drugs to Lower Addiction Risk, Fewer Severe Outcomes

BMJ Study Ties GLP-1 Drugs to Lower Addiction Risk and Fewer Overdoses in VA Patients

German Endocrinologist Calls for Statutory Coverage of Weight-Loss Injections as Illegal Procurement Rises

CDC Survey Finds Record Youth Obesity as Adult Rates Edge Lower

Berlin Patient Begins Donanemab as Germany’s New Alzheimer Therapies Roll Out

Boots' £10 Tuesday Cuts Plant Sterol Cholesterol Tablets to 17p Each

Novo’s Wegovy Pill Posts Quick Uptake, Boosting Shares as Oral GLP‑1 Battle Nears

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

FDA Approves First Oral Wegovy Weight-Loss Pill as U.S. Availability Begins

NHS Reiterates Metformin Safety Guidance On When To Call 999

Wegovy Launches in Argentina With Adolescent Indication and Proven Cardiovascular Benefit

Walmart Adds Same-Day Delivery of Refrigerated Prescriptions With Grocery Orders

NHS Prescribes Mounjaro to High-Risk Patients as Private Users Report Dramatic Results

P2Y12 Inhibitors Outperform Aspirin in Preventing Heart Attacks and Strokes Without Raising Bleeding Risk

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

Pfizer Settles $59.7M Kickback Allegations Tied to Acquired Migraine Drug

Oprah Winfrey Reflects on Weight Loss Drugs and Misconceptions About Thin People

Eli Lilly Lowers 2024 Revenue Forecast Due to Slower Weight-Loss Drug Growth

French Government Intervenes in Doliprane Ownership Amid Worker Strikes